Porcia A. Thurston
Associate Director, Contracts Specialist | She/Her/Hers
Associate Director, Contracts Specialist | She/Her/Hers
Areas of Focus
Overview
Porcia Thurston brings over 16 years of experience in the biopharmaceutical industry to her work for clients.
She leverages her prior in-house experience to skillfully and pragmatically draft, negotiate, and manage agreements for a wide range of research and clinical development matters, including study start-up and complex master services agreements, site agreements, data privacy agreements, and informed consents for large, multinational clinical studies of therapeutic products.
Career & Education
- Clinical Contracts and Finance Associate, Gilead Sciences, Inc.
-
- Reviewed, drafted, negotiated and managed a variety of clinical trial agreements, amendments, and assignment agreements
- Worked in project management of clinical trials
-
- Clinical Contracts and Finance Associate, Gilead Sciences, Inc.
- University of California, Los Angeles, B.S., magna cum laude, Political Science
- University of California, Los Angeles, J.D., Critical Race Studies
Representative Matters
- Drafted, negotiated, and coordinated clinical trial and related agreements for multiple clinical trials of precision medicine therapeutics, including phase 2/3 trials involving over 80 sites in North America, Europe, and Asia.
- Drafted, negotiated, and coordinated clinical trial and related templates and agreements for multiple clinical trials of a bifunctional monoclonal antibody that targets B cells for multiple autoimmune diseases, including phase 3 trials involving over 100 sites in North America, South America, Europe, and Asia.
- Drafted, negotiated, and managed clinical trial templates and related agreements for a Phase 2 cardiovascular clinical trial of a PDE9 inhibitor involving approximately 145 sites in Western and Eastern Europe.
- Drafted, negotiated, and coordinated multiple Phase 2 clinical trials of an aurora kinase inhibitor involving over 60 sites in the U.S. and Europe.
- Drafted and negotiated agreements with service providers for clinical and preclinical studies of therapeutic and medical device products, including multi-million-dollar master services agreements with large global research organizations.